Intracerebral Hemorrhage Clinical Trials in Columbus, Ohio

4 studies are recruiting for intracerebral hemorrhage in Columbus, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. CoMind Early Feasibility Study

   The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pres…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ohio State University, Columbus, Ohio

   Locations

   16 in total

   Run by

   CoMind Technologies Limited

   See if you can join NCT06368648 on ClinicalTrials.gov

2. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

   The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is tha…

   Stage

   Phase 3

   Ages

   18 to 80

   Site

   OSU Wexner Medical Center, Columbus, Ohio

   Locations

   89 in total

   Run by

   Joseph Broderick, MD

   See if you can join NCT07227246 on ClinicalTrials.gov

3. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

   Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   OSU Wexner Medical Center, Columbus, Ohio

   Locations

   187 in total

   Run by

   Yale University

   See if you can join NCT03907046 on ClinicalTrials.gov

4. Augmented Renal Clearance in Neurocritical Care

   Stroke, severe brain injury, uncontrolled seizures and brain infections are the most common life-threatening neurological illnesses in the world with an estimated combined annual hospital management cost of up to 44 billion dollars. Seizures and infections are common complications following acute n…

   Stage

   Not phased

   Ages

   18 to 85

   Site

   The Ohio State University Wexner Medical Center, Columbus, Ohio

   Locations

   3 in total

   Run by

   University of Alberta

   See if you can join NCT07410624 on ClinicalTrials.gov